Autopsy report · NCT07314060

A Clinical Trial of TQH2929 Injection in Patients With Acute Flare-up of Generalized Pustular Psoriasis

“Due to the company's strategic adjustment in product portfolio, this study has been voluntarily terminated.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 months before it started.
• Ran for about 4 months before it stopped.
• 36 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Sponsor type

Industry

Conditions

Generalized Pustular Psoriasis

Interventions

TQH2929 Injections; TQH2929 Placebo

Participants

36

Sites

31

Countries

China

Trials that died the same way

• Long-Term Follow-up Study of Subjects With Fabry Disease Who Received Lentiviral Gene Therapy in Study AVRO-RD-01-201
  “This study was voluntarily terminated due to a business decision not to proceed, and not due to any safety or efficacy issue.” (80% match in meaning)
• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of BFKB8488A Compared With Placebo in Participants With Non-Alcoholic Steatohepatitis
  “The study was terminated due to strategic business reasons.” (77% match in meaning)
• GT201 Injection in Combination With Teraplizumab Injection for Treatment of Patients With Non-small Cell Lung Cancer
  “The study was terminated from a business perspective.” (76% match in meaning)
• Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
  “This study was terminated early due to company decision.” (75% match in meaning)
• A Study of AC682 In Chinese Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancer
  “Voluntarily terminate the study since the sponsor's development strategy was adjusted.” (75% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.